Plain-English translation of NCT01281735 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an international research study that gathers medical information from children and teenagers diagnosed with chronic myeloid leukemia, a rare blood cancer. Researchers want to learn more about how this disease affects young people and how well different treatments—including imatinib mesylate (a targeted oral medication) and stem cell transplants—work in this age group.
Chronic myeloid leukemia is extremely rare in children, and doctors don't yet have enough information about how the disease behaves or responds to treatment in young patients compared to adults. This study aims to close that knowledge gap by collecting experiences from children and teenagers across Europe, so future young patients receive better care.
You likely qualify if…
You likely don't qualify if…
As a participant, your doctors would share your medical records and treatment information with the study team—including details about your diagnosis, test results, and how you respond to therapy. You would not need to take any new medication or undergo extra procedures; the study simply tracks information that is already being collected as part of your regular cancer care. The study is ongoing and will continue to follow participants' progress over time.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
Australia
Austria
Belarus
Belgium
Brazil